Human growth hormone is a multi-functional hormone in the body. It is produced by the pituitary gland and reaches its peak of production during childhood and puberty years. HGH is associated with growth and metabolic processes.
Human growth hormone is investigated for its many functions in treating many diseases other than the HGH diseases. These treatments of these HGH diseases are also the subject of research because of certain side effects.
One of the side effects of the earliest method in treating HGH deficiency is the Creutzfeldt - Jakob disease (CJD). This disease was manifested by people who were treated with cadaver-GH. Cadaver-GH was the first method to be used in treating HGH diseases and involved purifying HGH from a dead body. The CJD cases in relation to HGH treatment rise in 2003 making it impossible for cadaver-GH to be continued. CJD is a degenerative, odd and perpetually fatal brain disorder.
There are about 200 cases of CJD in the U.S every year. CJD brings about lapses in memory, changes in behavior, visual disturbance and lack of organization. Coma may also occur as CJD advances. CJD often happens to people who are old. The CJD is further categorized into three types:
1.) Sporadic CJD
2.) Hereditary CJD
3.) Acquired CJD
The cases of CJD that is associate with HGH treatment is of the third type. The patients acquired CJD through the performance of a medical procedure. The dreadful fact about CJD is that there are no available treatments for it. Scientists and researchers have tested many drugs in hope of finding possible treatments for CJD. So far, these drugs proved to be futile and do not help in treating CJD.